| Active, not recruiting | N/A | 120 | RoW | Metformin, Liraglutide, empagliflozin, Vildagliptin | Alexandria University, Eva Pharma | Fatty Liver, Nonalcoholic, Diabetes Mellitus, Type 2 | 09/21 | 09/22 | | |
| Completed | N/A | 239990 | Europe | Canagliflozin, DPP4 inhibitor, Liraglutide, Saxagliptin, 2nd generation Sulfonylurea | AstraZeneca | Type 2 Diabetes Mellitus | 08/23 | 08/23 | | |
| Active, not recruiting | N/A | 150 | RoW | Metformin, Glucophage, Gliclazide, Diamicron, Diamicron MR, Sitagliptin, Januvia, Liraglutide, Victoza, Pioglitazone, Actos, Dapagliflozin, Forxiga, Farxiga, human insulin, novorapid, glargine | Weill Cornell Medical College in Qatar, Hamad Medical Corporation, Sidra Medical and Research Center, University of Hull | Diabetes Mellitus Type 2 | 10/23 | 10/24 | | |
